Search Results  for 'ELOSSb.ST'

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Elos Medtech AB: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

01 Aug 2015 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Elos Medtech AB

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

25 Jul 2015 Wright Reports 56 $75.00

Company Snapshot - Elos AB

A director at Elos AB maiden bought 40,000 shares at 0.000SEK and the significance rating of the trade was 100/100. Is that ...

18 May 2015 Directors Deals Ltd. 1 $12.00

Elos AB (ELOS B) - Financial Analysis Review

Elos AB (ELOS B) - Financial Analysis Review Summary Elos AB (Elos) is a medical technology company. It operates busine...

27 Apr 2015 GlobalData 32 $125.00

Elos AB (ELOS B) - Financial Analysis Review

Elos AB (ELOS B) - Financial Analysis Review Summary Elos AB (Elos) is a medical technology company. It operates busine...

17 Feb 2015 GlobalData 30 $125.00

Is Elos AB a Good Long-Term Investment?

24 Oct 2014 Sadif Analytics Prime 12 $25.00

Wright Investors Service Core Report for Elos AB

A textual review of the financial results of Elos AB versus Genetix Group PLC, WaveLight AG and W.O.M. World of Medicine AG. ...

03 May 2012 Wright Reports 10 $115.00

Company Snapshot - Elos AB

A director at Elos AB sold 4,000 shares at 0.000SEK and the significance rating of the trade was 67/100. Is that information ...

16 Dec 2010 Directors Deals Ltd. 1 $10.00

Wright Investors Service Core Report for Elos AB

A textual review of the financial results of Elos AB versus WaveLight AG, W.O.M. World of Medicine AG and Genetix Group PLC. ...

30 Jun 2009 Wright Reports 10 $35.00

ISS Report on Elos AB (frmrl WESTERGYLLEN AB)

30 Apr 2009 RiskMetrics Group 6 $100.00